ARTICLE | Clinical News
LipoTECA: Began a second Canadian Phase III trial, as an interim analysis of the first has shown statistically significant differences between the drug and a pl
July 31, 1995 7:00 AM UTC
Draxis Health Inc. (DRAXF), Mississauga, Ontario Product: LipoTECA, liposomal cream formulation of TECA, an approved oral drug that is a plant derivative Indication: Keloid scars Status: Began a secon...